HedgePath Pharmaceuticals, Inc. HPPI Company Overview

New Post Public Reply Private Reply Replies (0) Message Board

Sep 14, 2013 at 10:05 PM

HedgePath Pharmaceuticals, Inc. HPPI Company Overview

Stock Message Board http://investorshangout.com/search?q=HPPI&...mp;yt1=Go!

HedgePath Pharmaceuticals, Inc. HPPI Current Price and Quotes
Last Price 0.15
Previous Close 0.16 Open 0.15
Daily Range 0.15 - 0.15 52wk Range 0.1799 - 0.01
Volume 1,050 Dividend N/A
Average Vol (3m) 10,433 Yield N/A
HedgePath Pharmaceuticals, Inc. HPPI
Company Information

324 S. Hyde Park Avenue
Ste. 350
Tampa, FL 33606

Website: http://www.cbi-biotech.com
Phone: 813-864-2559
Email: info@cbi-biotech.com

HedgePath Pharmaceuticals, Inc. HPPI
HedgePath Pharmaceuticals, Inc. HPPI
Financial Reportings and Disclosures

Reporting Status U.S. Reporting: SEC Filer
Audited Financials Not Available
Latest Report Jun 30, 2013 10-Q
CIK 0001042418
Fiscal Year End 12/31
OTC Marketplace OTCQB
Profile Data

SIC - Industry Classification 8731 - Commercial physical research
Incorporated In: DE, USA
Year of Inc. Not Available
Employees Not Available
Company Officers/Contacts

Nicholas Virca CEO, President
Garrison J. Hasara CFO, Secretary, Treasurer
Company Directors

Not Available
Company Notes

Formerly=Commonwealth Biotechnologies, Inc. until 8-2013
Service Providers

Auditor/Accountant
Cherry Bekaert LLP
401 East Jackson St
Suite 3400
Tampa, TN, 33602
United States

Legal Counsel
Not Available
Investor Relations Firm
Not Available

HedgePath Pharmaceuticals, Inc. HPPI
HPPI Security Details

Share Structure

Market Value1 $2,334,076 a/o Sep 13, 2013
Shares Outstanding 15,560,504 a/o May 20, 2013
Float Not Available
Authorized Shares Not Available
Par Value No Par Value
Shareholders

Shareholders of Record Not Available
Security Notes

New Issue=10-97 1,015,000 shs at $6 by Anderson & Strudwick, Inc.
Note = Delisted from NASDAQ on 01/22/10
Short Selling Data

Short Interest 0 (-100%)
Jan 31, 2012
Significant Failures to Deliver No
Transfer Agent(s)

Computershare Trust Company Inc.

HedgePath Pharmaceuticals, Inc. HPPI Recent News

Sept 11, 2013 HedgePath Pharmaceuticals Enters into Key Collaboration with Mayne Pharma

HedgePath Pharmaceuticals, Inc. HPPI Financials
Period Ending Dec 31, 2012 Dec 31, 2011 Dec 31, 2010 Dec 31, 2009
Total Revenue - - - 100
Cost of Revenue - - - -
Gross Profit - - - 100
Operating Expenses

Research and Development - - - -
Sales, General and Admin. 561 982 1,026 1,894
Non-Recurring Items - - - -
Other - - - -
Operating Income (561) (982) (1,026) (1,794)
Income From Continuing Operations

Add'l Income/Expense Items 747 935 615 (196)
Earnings Before Interest and Tax 186 (47) (411) (1,991)
Interest Expense - 218 233 465
Earnings Before Tax 186 (265) (645) (2,456)
Income Tax - - - -
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations 186 (265) (645) (2,456)
Non Recurring Events

Discontinued Operations - 37 (360) 479
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income 186 (228) (1,004) (2,360)
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders 186 (228) (1,004) (2,360)

HPPI HedgePath Pharmaceuticals, Inc. Research DD Guide

HPPI HedgePath Pharmaceuticals, Inc. Stock Message Board http://investorshangout.com/search?q=HPPI&...mp;yt0=Go!
HPPI HedgePath Pharmaceuticals, Inc. Stock Quote http://www.otcmarkets.com/stock/HPPI/quote
HPPI HedgePath Pharmaceuticals, Inc. Stock Chart http://www.otcmarkets.com/stock/HPPI/chart
HPPI HedgePath Pharmaceuticals, Inc. Company Info http://www.otcmarkets.com/stock/HPPI/company-info
HPPI HedgePath Pharmaceuticals, Inc. Recent News http://www.otcmarkets.com/stock/HPPI/news
HPPI HedgePath Pharmaceuticals, Inc. Financials http://www.otcmarkets.com/stock/HPPI/financials
HPPI HedgePath Pharmaceuticals, Inc. Filings and Disclosure http://www.otcmarkets.com/stock/HPPI/filings
HPPI HedgePath Pharmaceuticals, Inc. Short Sales http://www.otcmarkets.com/stock/HPPI/short-sales
HPPI HedgePath Pharmaceuticals, Inc. Insider Disclosure http://www.otcmarkets.com/stock/HPPI/insider-transactions
HPPI HedgePath Pharmaceuticals, Inc. Research Reports http://www.otcmarkets.com/stock/HPPI/research
HPPI HedgePath Pharmaceuticals, Inc. Summary http://finance.yahoo.com/q?s=HPPI
HPPI HedgePath Pharmaceuticals, Inc. Historical Prices http://finance.yahoo.com/q/hp?s=HPPI+Historical+Prices
HPPI HedgePath Pharmaceuticals, Inc. Interactive Chart http://finance.yahoo.com/echarts?s=HPPI
HPPI HedgePath Pharmaceuticals, Inc. Basic Chart http://finance.yahoo.com/q/bc?s=HPPI+Basic+Chart
HPPI HedgePath Pharmaceuticals, Inc. Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=HPPI+Basic+Tech.+Analysis
HPPI HedgePath Pharmaceuticals, Inc. Headlines http://finance.yahoo.com/q/h?s=HPPI+Headlines
HPPI HedgePath Pharmaceuticals, Inc. Press Releases http://finance.yahoo.com/q/p?s=HPPI+Press+Releases
HPPI HedgePath Pharmaceuticals, Inc. Company Profile http://finance.yahoo.com/q/pr?s=HPPI+Profile
HPPI HedgePath Pharmaceuticals, Inc. Key Statistics http://finance.yahoo.com/q/ks?s=HPPI+Key+Statistics
HPPI HedgePath Pharmaceuticals, Inc. Industry http://finance.yahoo.com/q/in?s=HPPI+Industry
HPPI HedgePath Pharmaceuticals, Inc. Major Holders http://finance.yahoo.com/q/mh?s=HPPI+Major+Holders
HPPI HedgePath Pharmaceuticals, Inc. Insider Transactions http://finance.yahoo.com/q/it?s=HPPI+Insider+Transactions
HPPI HedgePath Pharmaceuticals, Inc. Insider Roster http://finance.yahoo.com/q/ir?s=HPPI+Insider+Roster
HPPI HedgePath Pharmaceuticals, Inc. Income Statement http://finance.yahoo.com/q/is?s=HPPI
HPPI HedgePath Pharmaceuticals, Inc. Balance Sheet http://finance.yahoo.com/q/bs?s=HPPI
HPPI HedgePath Pharmaceuticals, Inc. Cash Flow http://finance.yahoo.com/q/cf?s=HPPI+Cash+Flow&annual
HPPI HedgePath Pharmaceuticals, Inc. Nasdaq http://www.nasdaq.com/symbol/HPPI
HPPI HedgePath Pharmaceuticals, Inc. Market Watch http://www.marketwatch.com/investing/stock/HPPI
HPPI HedgePath Pharmaceuticals, Inc. Bloomberg http://www.bloomberg.com/quote/HPPI:US
HPPI HedgePath Pharmaceuticals, Inc. Morningstar http://quotes.morningstar.com/stock/s?t=HPPI
HPPI HedgePath Pharmaceuticals, Inc. Bussinessweek http://investing.businessweek.com/research/st...icker=HPPI
HPPI HedgePath Pharmaceuticals, Inc. Barchart http://www.barchart.com/quotes/stocks/HPPI
HPPI HedgePath Pharmaceuticals, Inc. OTC Short Report http://otcshortreport.com/index.php?index=HPPI
HPPI HedgePath Pharmaceuticals, Inc. Investopedia http://www.investopedia.com/markets/stocks/HPPI/?wa=0

List of all stock message boards and tickers for OTC BB Pinks & Penny Stocks http://investorshangout.com/board?categoryid=OTC

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

UEG's New Advisory Board: Elevating Patient Voices

Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...

Lundbeck's Board Leadership Transitions into New Era

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...

AEVEX Faces 48-Hour Deadline for Investor Class Action

Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....

Faith and Resilience in China: The Legacy of the Long March

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...

Tomorrowland's Shanghai Return: An Electri-Lifesaver

You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...

Antheia Secures $80M for Critical Medicine Onshoring

Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...

ASTS Faces a Legal Countdown – Investors Take Note

AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...